Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study.
about
Neuropathic cancer pain: What we are dealing with? How to manage it?Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic PainIntrathecal ziconotide for neuropathic pain: a review.Intraspinal techniques for pain management in cancer patients: a systematic review.Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development.Spinal mechanisms of pain and analgesia.P/Q-type calcium channel modulators.Ziconotide: a clinical update and pharmacologic review.Intrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesics.Intrathecal drug administration in chronic pain syndromes.The Pharmacology of Spinal Opioids and Ziconotide for the Treatment of Non-Cancer Pain.Ziconotide Monotherapy: A Systematic Review of Randomised Controlled Trials.The Polyanalgesic Consensus Conference (PACC): Recommendations for Trialing of Intrathecal Drug Delivery Infusion Therapy.The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.[Experience in treatment of patients with neuropathic facial pain using ziconotide].Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy.Multimodal intrathecal analgesia in refractory cancer pain.The failed and future promise of intraspinal drug administration for neurologic disorders.Recent advances in select interventional approaches to cancer-related pain.
P2860
Q26998945-07984809-D5EB-4770-90CF-5D49116CDD0CQ28069472-36FBC9E5-D815-470B-9FBB-049B2C1296B3Q37580048-466333A7-E4D2-4454-B2E0-D5A684421EF2Q37639925-8F8DB94B-6281-455A-8170-32B7AD22F4EBQ37899194-38994A09-5967-4B13-B445-4E68BDCBD2C5Q38013181-DC0B3665-C095-493E-B9DF-895C1AC25541Q38016449-7C89D87E-D89D-41D8-92B0-EA7747FBBC95Q38093859-13BC8F54-A16B-47C6-AFE4-C0E4D71BC33CQ38133766-F42A5046-2C40-4B0A-A188-839655623C93Q38151939-C6EFF4E6-612A-4E1B-80AC-728CDCE3B390Q38727834-EE3113F6-1B53-4683-B5BA-611C8C9995F0Q38727837-F0D36D3C-D8B6-4862-A0B0-FCBE15A95A0FQ39064694-46111D54-0EDE-4317-99D8-73569A0BA9D0Q39064699-346CBD98-0AF9-4A41-9697-4623FA42E21FQ39261367-120CF0F6-A3EF-4AB8-A7E7-B07C81E29539Q39523470-041DC761-22C6-4B44-8DC6-91C18FAB87E1Q40076190-09EEA534-5B30-4DAC-BB0E-12334DFBC8ADQ44295791-019385B0-F7CC-4D7B-8D28-71CE55AA498AQ46889684-BC497735-0E74-4C25-901F-E9E7129B9312
P2860
Continuous Intrathecal Infusion of Ziconotide for Treatment of Chronic Malignant and Nonmalignant Pain Over 12 Months: A Prospective, Open-label Study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@en
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@nl
type
label
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@en
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@nl
prefLabel
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@en
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@nl
P2093
P2860
P1433
P1476
Continuous Intrathecal Infusio ...... Prospective, Open-label Study.
@en
P2093
David J Ellis
Dawn McGuire
Elan Study 95-002 Group
Gene W Grove
Mark S Wallace
Peter S Staats
Piet Vercruysse
Sanjeeva Dissanayake
Steven G Charapata
P2860
P356
10.1111/J.1525-1403.2007.00141.X
P577
2008-01-01T00:00:00Z